The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Activation of Aryl Hydrocarbon Receptor (AhR) Leads to Reciprocal Epigenetic Regulation of FoxP3 and IL-17 Expression and Amelioration of Experimental Colitis
Open accessAbstract
BACKGROUND: Aryl hydrocarbon receptor (AhR), a transcription factor of the bHLH/PAS family, is well characterized to regulate the biochemical and toxic effects of environmental chemicals. More recently, AhR activation has been shown to regulate the differentiation of Foxp3(+) Tregs as well as Th17 cells. However, the precise mechanisms are unclear. In the current study, we investigated the effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a potent AhR ligand, on epigenetic regulation leading to altered Treg/Th17 differentiation, and consequent suppression of colitis. METHODOLOGY/PRINCIPAL FINDINGS: Dextran sodium sulphate (DSS) administration induced acute colitis in C57BL/6 mice, as shown by significant weight loss, shortening of colon, mucosal ulceration, and increased presence of CXCR3(+) T cells as well as inflammatory cytokines. Interestingly, a single dose of TCDD (25 µg/kg body weight) was able to attenuate all of the clinical and inflammatory markers of colitis. Analysis of T cells in the lamina propria (LP) and mesenteric lymph nodes (MLN), during colitis, revealed decreased presence of Tregs and increased induction of Th17 cells, which was reversed following TCDD treatment. Activation of T cells from AhR(+/+) but not AhR (-/-) mice, in the presence of TCDD, promoted increased differentiation of Tregs while inhibiting Th17 cells. Analysis of MLN or LP cells during colitis revealed increased methylation of CpG islands of Foxp3 and demethylation of IL-17 promoters, which was reversed following TCDD treatment. CONCLUSIONS/SIGNIFICANCE: These studies demonstrate for the first time that AhR activation promotes epigenetic regulation thereby influencing reciprocal differentiation of Tregs and Th17 cells, and amelioration of inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992 · cited 1×
“The chronic nature of inflammation appears to be a polarized dysregulated immune response due to imbalance of immune homeostasis involving Th1, Th17, and/or Th2 cells [20,21,22,23].”
BackgroundHarrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
Chen, W., Jin, W., Hardegen, N., Lei, K.-J., Li, L., Marinos, N., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,699
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Podolsky, D. K. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020831 · Cited by 3,159
Fitzgerald, M., Hayward, I. P., Thomas, A. C., Campbell, J. H., & CAMPBELL, G. R. (1995) · Cited by 2,552
Read, S., Malmström, V., & Powrie, F. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.295 · Cited by 2,205
Bonecchi, R., Bianchi, G., Bordignon, P. P., D'Ambrosio, D., Lang, R., Borsatti, A., Sozzani, S., Allavena, P., Gray, P. A., Mantovani, A., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.1.129 · Cited by 2,014
Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor
Quintana, F. J., Basso, A. S., Iglesias, A. H., Korn, T., Farez, M. F., Bettelli, E., Caccamo, M., Oukka, M., & Weiner, H. L. (2008) · Nature · doi:10.1038/nature06880 · Cited by 1,865
IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells
Korn, T., Bettelli, E., Gao, W., Awasthi, A., Jäger, A., Strom, T. B., Oukka, M., & Kuchroo, V. K. (2007) · Nature · doi:10.1038/nature05970 · Cited by 1,848
The immunological and genetic basis of inflammatory bowel disease
Bouma, G., & Strober, W. (2003) · Nature Reviews Immunology · doi:10.1038/nri1132 · Cited by 1,767
The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
Veldhoen, M., Hirota, K., Westendorf, A. M., Buer, J., Dumoutier, L., Renauld, J.-C., & Stockinger, B. (2008) · Nature · doi:10.1038/nature06881 · Cited by 1,634
Innate IL-17-producing cells: the sentinels of the immune system
Cua, D. J., & Tato, C. M. (2010) · Nature Reviews Immunology · doi:10.1038/nri2800 · Cited by 1,578
A Critical Role for Dnmt1 and DNA Methylation in T Cell Development, Function, and Survival
Lee, P. P., Fitzpatrick, D. R., Beard, C., Jessup, H. K., Lehar, S., Makar, K. W., Pérez-Melgosa, M., Sweetser, M. T., Schlissel, M. S., Nguyen, S., et al. (2001) · Immunity · doi:10.1016/s1074-7613(01)00227-8 · Cited by 1,275
Fuss, I. J., Neurath, M., Boirivant, M., Klein, J. S., de la Motte, C., Strong, S. A., Fiocchi, C., & Strober, W. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.3.1261 · Cited by 1,227
Cutting Edge: Cure of Colitis by CD4+CD25+ Regulatory T Cells
Mottet, C., Uhlig, H. H., & Powrie, F. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.3939 · Cited by 927
Fuss, I. J., Heller, F., Boirivant, M., Leon, F., Yoshida, M., Fichtner-Feigl, S., Yang, Z., Exley, M., Kitani, A., Blumberg, R. S., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19836 · Cited by 797
Distinct Cytokine Patterns Identified from Multiplex Profiles of Murine DSS and TNBS-Induced Colitis
Alex, P., Zachos, N. C., Nguyen, T., Gonzales, L., Chen, T.-E., Conklin, L. S., Centola, M., & Li, X. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20753 · Cited by 750
Zorn, E., Nelson, E. A., Mohseni, M., Porcheray, F., Kim, H., Litsa, D., Bellucci, R., Raderschall, E., Canning, C., Soiffer, R. J., et al. (2006) · Blood · doi:10.1182/blood-2006-02-004747 · Cited by 740
Epigenetic control of T-helper-cell differentiation
Wilson, C. B., Rowell, E., & Sekimata, M. (2009) · Nature Reviews Immunology · doi:10.1038/nri2487 · Cited by 682
Aryl hydrocarbon receptors: diversity and evolution
Hahn, M. E. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00070-4 · Cited by 642
CREB/ATF-dependent T cell receptor–induced FoxP3 gene expression: a role for DNA methylation
Kim, H.-P., & Leonard, W. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070109 · Cited by 597
Veldhoen, M., Hirota, K., Christensen, J., O'Garra, A., & Stockinger, B. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081438 · Cited by 520
The aryl hydrocarbon receptor in immunity
Esser, C., Rannug, A., & Stockinger, B. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.06.005 · Cited by 447
The aryl hydrocarbon receptor: a perspective on potential roles in the immune system
Stevens, E. A., Mezrich, J. D., & Bradfield, C. A. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03054.x · Cited by 413
Davidson, N. J., Leach, M. W., Fort, M. M., Thompson-Snipes, L., Kühn, R., Müller, W., Berg, D. J., & Rennick, D. M. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.1.241 · Cited by 402
Egger, B., Bajaj-Elliott, M., MacDonald, T. T., Inglin, R., Eysselein, V. E., & Büchler, M. W. (2000) · Digestion · doi:10.1159/000007822 · Cited by 384
Ah receptor: Dioxin-mediated toxic responses as hints to deregulated physiologic functions
Bock, K. W., & Köhle, C. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.01.017 · Cited by 337
T Helper Cell Differentiation: Regulation by cis Elements and Epigenetics
Lee, G. R., Kim, S. T., Spilianakis, C. G., Fields, P. E., & Flavell, R. A. (2006) · Immunity · doi:10.1016/j.immuni.2006.03.007 · Cited by 321
Akimzhanov, A. M., Yang, X. O., & Dong, C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.c600322200 · Cited by 302 · cited 1×
“In another study, it was noted that Th17 cell differentiation was accompanied by epigenetic changes at IL-17 gene promoter and suggested that similar to other T helper cell lineages, epigenetic modification is an integral part of Th17 cell differentiation [56].”
ResultAn introduction to the molecular basics of aryl hydrocarbon receptor biology
Abel, J., & Haarmann-Stemmann, T. (2010) · Biological Chemistry · doi:10.1515/bc.2010.128 · Cited by 296
Regulatory T cells and intestinal homeostasis
Coombes, J. L., Robinson, N. J., Maloy, K. J., Uhlig, H. H., & Powrie, F. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00250.x · Cited by 275
Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice
Ito, R., Kita, M., Shin-Ya, M., Kishida, T., Urano, A., Takada, R., Sakagami, J., Imanishi, J., Iwakura, Y., Okanoue, T., et al. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.09.019 · Cited by 251
FOXP3 Promoter Demethylation Reveals the Committed Treg Population in Humans
Janson, P. C. J., Winerdal, M. E., Marits, P., Thörn, M., Ohlsson, R., & Winqvist, O. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001612 · Cited by 234
Hu, W., Sorrentino, C., Denison, M. S., Kolaja, K., & Fielden, M. R. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.032748 · Cited by 225
Recent advances in understanding the mechanisms of TCDD immunotoxicity
Kerkvliet, N. I. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00179-5 · Cited by 217
Singh, U. P., Singh, N. P., Singh, B., Hofseth, L. J., Price, R. L., Nagarkatti, M., & Nagarkatti, P. S. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.160838 · Cited by 206
Self-citationMarshall, N. B., & Kerkvliet, N. I. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05125.x · Cited by 195
Singh, N. P., Hegde, V. L., Hofseth, L. J., Nagarkatti, M., & Nagarkatti, P. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.038984 · Cited by 173
Self-citationKerkvliet, N. I., Steppan, L. B., Vorachek, W., Oda, S., Farrer, D., Wong, C. P., Pham, D., & Mourich, D. V. (2009) · Immunotherapy · doi:10.2217/imt.09.24 · Cited by 160
Ah receptor and NF-κB interplay on the stage of epigenome
Tian, Y. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.10.023 · Cited by 155
Evidence for the Induction of Apoptosis in Thymocytes by 2,3,7,8-Tetrachlorodibenzo-p-dioxinin Vivo
Kamath, A. B., Xu, H., Nagarkatti, P. S., & Nagarkatti, M. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.8049 · Cited by 148
Self-citationInhibition of IFN-γ-Inducible Protein-10 Abrogates Colitis in IL-10−/− Mice
Singh, U. P., Singh, S., Taub, D. D., & Lillard, J. W. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.3.1401 · Cited by 146
Self-citationNagarkatti, P. S., Sweeney, G. D., Gauldie, J., & Clark, D. A. (1984) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(84)90261-8 · Cited by 105
Self-citationScheerens, H., Hessel, E. M., Malefyt, R. D. W., Leach, M. W., & Rennick, D. M. (2001) · European Journal of Immunology · Cited by 105
Pertussis Toxin by Inducing IL-6 Promotes the Generation of IL-17-Producing CD4 Cells
Chen, X., Howard, O. M. Z., & Oppenheim, J. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.10.6123 · Cited by 103
Clark, D. A., Gauldie, J., Szewczuk, M. R., & Sweeney, G. D. (1981) · Experimental Biology and Medicine · doi:10.3181/00379727-168-41275 · Cited by 101
Takamura, T., Harama, D., Matsuoka, S., Shimokawa, N., Nakamura, Y., Okumura, K., Ogawa, H., Kitamura, M., & Nakao, A. (2010) · Immunology and Cell Biology · doi:10.1038/icb.2010.35 · Cited by 98
Camacho, I. A., Singh, N. P., Hegde, V. L., Nagarkatti, M., & Nagarkatti, P. S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.90 · Cited by 97
Self-citationBeedanagari, S. R., Taylor, R. T., Bui, P. H., Wang, F., Nickerson, D. W., & Hankinson, O. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.064899 · Cited by 87
Elevated serum eotaxin levels in patients with inflammatory bowel disease
Mir, A., Mínguez, M., Tatay, J., Pascual, I., Pena, A., Sánchiz, V., Almela, P., Mora, F., & Benages, A. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)04043-1 · Cited by 81
Kamath, A. B., Camacho, I. A., Nagarkatti, P. S., & Nagarkatti, M. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8753 · Cited by 68
Self-citationIFN-γ-Inducible Chemokines Enhance Adaptive Immunity and Colitis
Singh, U. P., Singh, S., Iqbal, N., Weaver, C. T., McGhee, J. R., & Lillard, J. W. (2003) · Journal of Interferon & Cytokine Research · doi:10.1089/107999003322485099 · Cited by 60
Self-citationSingh, N. P., Nagarkatti, M., & Nagarkatti, P. S. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.028365 · Cited by 60
Self-citationDesaulniers, D., Xiao, G.-H., Leingartner, K., Chu, I., Musicki, B., & Tsang, B. K. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi178 · Cited by 50
Singh, N. P., Nagarkatti, M., & Nagarkatti, P. S. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.043406 · Cited by 48
Self-citation
Cited by
Rothhammer, V., & Quintana, F. J. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0125-8 · Cited by 1,197
Regulation of the immune response by the aryl hydrocarbon receptor
Gutiérrez-Vázquez, C., & Quintana, F. J. (2018) · Immunity · doi:10.1016/j.immuni.2017.12.012 · Cited by 985
Aryl hydrocarbon receptor ligands in cancer: friend and foe
Murray, I. A., Patterson, A. D., & Perdew, G. H. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3846 · Cited by 883
Aryl hydrocarbon receptor and intestinal immunity
Lamas, B., Natividad, J. M., & Sokol, H. (2018) · Mucosal Immunology · doi:10.1038/s41385-018-0019-2 · Cited by 516
Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine
Campesato, L. F., Budhu, S., Tchaicha, J., Weng, C.-H., Gigoux, M., Cohen, I. J., Redmond, D., Mangarin, L., Pourpe, S., Liu, C., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17750-z · Cited by 516
Metadata
- Authors
- Singh, N. P., Singh, U. P., Singh, B., Price, R. L., Nagarkatti, M., & Nagarkatti, P. S.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-08-15
- Volume
- 6
- Issue
- 8
- Pages
- e23522
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1963856513
- Cited by
- 284
- References
- 57
- FWCI
- 10.96
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.